A challenging undertaking: Stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 3, 2016, Pages 953-955.e4

  Kucuk, Zeynep Yesim ^a   Bleesing, Jack J ^a   Marsh, Rebecca ^a   Zhang, Kejian ^a   Davies, Stella ^a   Filipovich, Alexandra H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CYCLOSPORIN; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE; TACROLIMUS; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ACUTE GRAFT VERSUS HOST DISEASE; CHILD; CHIMERA; CLINICAL ARTICLE; CYTOPENIA; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IPEX SYNDROME; LETTER; MYELOABLATIVE CONDITIONING; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; UMBILICAL CORD BLOOD; DIABETES MELLITUS, TYPE 1; DIARRHEA; GENETIC DISEASES, X-LINKED; GENETICS; IMMUNE SYSTEM DISEASES; IMMUNOLOGY; MUTATION; PROCEDURES; TREATMENT OUTCOME; X CHROMOSOMAL INHERITANCE;

DIABETES MELLITUS, TYPE 1; DIARRHEA; FORKHEAD TRANSCRIPTION FACTORS; GENES, X-LINKED; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNE SYSTEM DISEASES; MUTATION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84965076060     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.09.030     Document Type: Article

References (9)

1. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27:20-1.
2. Barzaghi F, Passerini L, Bacchetta R. Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol 2012;3:211.
3. Baud O, Goulet O, Canioni D, Le Deist F, Radford I, Rieu D, et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrowtransplantation. N Engl J Med 2001;344:1758-62.
4. Rao A, Kamani N, Filipovich A, Lee SM, Davies SM, Dalal J, et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Blood 2007;109:383-5.
5. Burroughs LM, Torgerson TR, Storb R, Carpenter PA, Rawlings DJ, Sanders J, et al. Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. J Allergy Clin Immunol 2010;126:1000-5.
6. Nademi Z, Slatter M, Gambineri E, Mannurita SC, Barge D, Hodges S, et al. Single centre experience of haematopoietic SCT for patients with immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Bone Marrow Transplant 2014;49:310-2.
7. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002;39:537-45.
8. Marsh RA, Vaughn G, Kim MO, Li D, Jodele S, Joshi S, et al. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood 2010;116:5824-31.
9. Burroughs LM, Nemecek ER, Torgerson TR, Storer BE, Talano JA, Domm J, et al. Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial. Biol Blood Marrow Transplant 2014;20:1996-2003.